Meridian Bioscience Inc. (VIVO)
NASDAQ: VIVO
· Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM
Meridian Bioscience Income Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Revenue | 301.58M | 333.02M | 343.55M | 339.29M | 313.32M | 317.9M | 305.85M | 327.13M | 299.16M |
Cost of Revenue | 130.88M | 144.66M | 144.47M | 139.82M | 124.56M | 116.75M | 110.91M | 113.46M | 108.81M |
Gross Profit | 170.7M | 188.36M | 199.08M | 199.46M | 188.76M | 201.15M | 194.93M | 213.67M | 190.36M |
Operating Income | 6.43M | 55.51M | 59.14M | 81.17M | 78.49M | 93.03M | 94.02M | 113M | 90.59M |
Interest Income | 19K | 17K | -10K | -12K | -8K | n/a | 20K | 23K | 40K |
Pretax Income | 5.47M | 54.32M | 57.54M | 79.44M | 75.95M | 90.45M | 90.34M | 109.92M | 89.52M |
Net Income | -2.7M | 42.46M | 43.41M | 62.42M | 59.97M | 71.41M | 71.24M | 87.08M | 70.14M |
Selling & General & Admin | 85.89M | 89.21M | 90.42M | 87.7M | 81.62M | 70.88M | 71.63M | 71.86M | 69.09M |
Research & Development | 24.32M | 24.34M | 24.04M | 24.08M | 24.45M | 23.91M | 24.57M | 25.23M | 24.56M |
Other Expenses | 8.33M | -69K | 5.88M | 5.88M | 5.68M | 14.69M | 9.1M | 9.1M | 9.29M |
Operating Expenses | 118.54M | 113.19M | 120.05M | 117.38M | 111.47M | 109.48M | 105.3M | 106.19M | 102.94M |
Interest Expense | 965K | 1.19M | 1.4M | 1.58M | 1.72M | 1.88M | 2.08M | 2.34M | 2.4M |
Selling & Marketing Expenses | 31.83M | 31.27M | 30.44M | 28.47M | 27.5M | 26.78M | 26.8M | 26.85M | 26.82M |
Cost & Expenses | 249.42M | 257.86M | 264.52M | 257.2M | 236.03M | 226.23M | 216.21M | 219.64M | 211.75M |
Income Tax Expense | 8.17M | 11.86M | 14.13M | 17.02M | 15.99M | 11.58M | 11.64M | 15.38M | 11.92M |
Shares Outstanding (Basic) | 43.9M | 44.73M | 44.47M | 44.26M | 43.44M | 43.36M | 43.33M | 43.24M | 43.1M |
Shares Outstanding (Diluted) | 43.9M | 44.73M | 44.47M | 44.26M | 44.03M | 44.09M | 44.1M | 44.12M | 43.78M |
EPS (Basic) | -0.06 | 0.97 | 0.99 | 1.42 | 1.38 | 1.65 | 1.65 | 2.02 | 1.63 |
EPS (Diluted) | -0.06 | 0.97 | 0.99 | 1.41 | 1.36 | 1.62 | 1.62 | 2.00 | 1.62 |
EBITDA | 19.6M | 72.02M | 75.48M | 97.21M | 93.41M | 103.77M | 103.96M | 123.53M | 102.42M |
EBIT | 6.77M | 55.84M | 59.27M | 81.02M | 77.67M | 92.33M | 92.42M | 112.26M | 91.91M |
Depreciation & Amortization | 16.51M | 16.51M | 16.55M | 16.19M | 15.74M | 13.06M | 13.16M | 12.89M | 12.13M |